Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency

Laboratory Investigation

Volumn 89, Issue 12, 2009, Pages 1348-1354

  Cox, Keith B ^a   Liu, Jian ^b   Tian, Liqun ^a   Barnes, Stephen ^c,d   Yang, Qinglin ^b   Wood, Philip A ^a,b,e  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c University of Alabama at Birmingham   (United States)

^d PURDUE UNIVERSITY   (United States)

^e BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; PHYTOESTROGEN;

ALFALFA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOMYOPATHY; CONTROLLED STUDY; DIET; ECHOCARDIOGRAPHY; ENZYME DEFICIENCY; FEMALE; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE SEPTUM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOYBEAN;

ACYL-COA DEHYDROGENASE, LONG-CHAIN; ANIMALS; BODY WEIGHT; CARDIOMEGALY; DIET; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FEMALE; ISOFLAVONES; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; ORGAN SIZE; PHYTOESTROGENS;

EID: 70549113382     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2009.86     Document Type: Article

References (27)

1. Rinaldo P, Matern D, Bennett MJ. Fatty acid oxidation disorders. Annu Rev Physiol 2002;64:477-502.
2. Andresen BS, Olpin S, Poorthuis BJ, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 1999;642:479-494.
3. Bonnefont JP, Taroni F, Cavadini P, et al. Molecular analysis of carnitine palmitoyltransferase II deficiency with hepatocardiomuscular expression. Am J Hum Genet 1996;585:971-978.
4. Pande SV. Carnitine-acylcarnitine translocase deficiency. Am J Med Sci 1999;3181:22-27.
5. Roe CR. Diagnostic approach to disorders of fat oxidation. Int Pediatr 1996;11:109-113.
6. Corr PB, Yamada KA. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. Herz 1995;203: 156-168.
7. Kurtz DM, Rinaldo P, Rhead WJ, et al. Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation. Proc Natl Acad Sci USA 1998;9526:15592-15597.
8. Cox KB, Hamm DA, Millington DS, et al. Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse. Hum Mol Genet 2001;1019:2069-2077.
9. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998;19:55-72.
10. Burke GL, Vitolins MZ, Bland D. Soybean isoflavones as an alternative to traditional hormone replacement therapy: are we there yet' J Nutr 2000;1303:664S-665S.
11. Lissin LW, Cooke JP. Phytoestrogens and cardiovascular health. J Am Coll Cardiol 2000;356:1403-1410.
12. Martin D, Song J, Mark C, et al. Understanding the cardiovascular actions of soy isoflavones: potential novel targets for antihypertensive drug development. Cardiovasc Hematol Disord Drug Targets 2008;84:297-312.
13. Mann GE, Bonacasa B, Ishii T, et al. Targeting the redox sensitive Nrf2-Keap1 defense pathway in cardiovascular disease: protection afforded by dietary isoflavones. Curr Opin Pharmacol 2009;9:139-145.
14. Carlson S, Peng N, Prasain JK, et al. Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females. Gend Med 2008;5(Suppl A):S76-S90.
15. Wenzel U, Fuchs D, Daniel H. Protective effects of soy-isoflavones in cardiovascular disease. Identification of molecular targets. Hamostaseologie 2008;28:85-88.
16. Coward L, Smith M, Kirk M, et al. Chemical modification of isoflavones in soyfoods during cooking and processing. Am J Clin Nutr 1998;686(Suppl):1486S- 1491S.
17. Roe CR, Ding J. Mitochondrial fatty acid oxidation disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn. McGraw-Hill: New York, 2001, pp 2297-2326.
18. Brown-Harrison MC, Nada MA, Sprecher H, et al. Very long chain acyl-CoA dehydrogenase deficiency: successful treatment of acute cardiomyopathy. Biochem Mol Med 1996;581:59-65.
19. Roe CR, Sweetman L, Roe DS, et al. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 2002;1102:259-269.
20. Yamaguchi S, Indo Y, Coates PM, et al. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1993;341:111-113.
21. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA 1991;26514:1861-1867.
22. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998;13910:4252-4263.
23. Setchell KD, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999;1293:758S-767S.
24. Schuler AM, Barnes S, Gower BA, et al. Dietary phytoestrogens increase metabolic resistance (cold tolerance) in long-chain acyl-CoA dehydrogenase-deficient mice. J Nutr 2004;1345:1028-1031.
25. Stauffer BL, Konhilas JP, Luczak ED, et al. Soy diet worsens heart disease in mice. J Clin Invest 2006;1161:209-216.
26. Ascuitto RJ, Ross-Ascuitto NT. Substrate metabolism in the developing heart. Semin Perinatol 1996;206:542-563.
27. Zarain-Herzberg A, Rupp H, Elimban V, et al. Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir. FASEB J 1996;1011:1303-1309.